Dana-Farber Cancer Institute

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Dana-Farber Cancer Institute
Sep 14, 2024, 12:17 | Blog
OncoInfluencers to Follow on Social Media: Dr. Monica Bertagnolli
We are thrilled to spotlight Dr. Monica Bertagnolli as a significant figure in the oncology…
Sep 13, 2024, 07:45 | Blog
Harold J. Burstein: Important story on cancer toll among Latinos featuring Narjust Florez
Harold J. Burstein, Breast cancer specialist and Professor at Dana-Farber Cancer Institute, shared a post on…
Sep 12, 2024, 09:57 | Insight
Meta-analysis of 20 RCTs with 14,995 Metastatic Castrate-sensitive Prostate Cancer patients
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer Institute, shared…
Sep 11, 2024, 10:52 | Blog
Thejus Jayakrishnan: My first faculty retreat at Dana-Farber Cancer Institute
Thejus Jayakrishnan, Gastrointestinal Oncologist at Dana-Farber Cancer Institute, shared a post on X: ''Had a…
Sep 10, 2024, 18:42 | Blog
Roupen Odabashian: Whole-Body MRI: A Comprehensive Approach to Cancer Screening with Growing Potential and Challenges
Roupen Odabashian posted on LinkedIn: "Disclaimer: My name is Roupen, and I am an Oncologist…
Sep 10, 2024, 13:52 | Career
Antonio Giordano: Excited to welcome Dr. Benjamin Ebert as next CEO of Dana Farber Cancer Institute
Antonio Giordano, President of Sbarro Health Research Organization, shared a post by The Boston Globe,…
Sep 8, 2024, 07:49 | Insight
Dana-Farber’s Breast Cancer in Young Adults Forum hosted by Ann Partridge
Dana-Farber’s Breast Oncology Center shared on X: “Join us on Oct 18th for the Breast…
Sep 8, 2024, 02:35 | Career
The New President and CEO of Dana-Farber Cancer Center - Benjamin Ebert
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center…
Sep 7, 2024, 19:36 | Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 7, 2024, 15:31 | Insight
Potential drug to target a rare childhood brain tumour - ICR
The Institute of Cancer Research (ICR) shared a post on LinkedIn: "News: Research reveals a…
Sep 7, 2024, 11:44 | Insight
Toni Choueiri: Celebrating Matt Freedman, the new David Goldstein Chair at Dana-Farber Cancer Institute
Toni Choueiri shared on X: “A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman,…
Sep 6, 2024, 13:28 | Insight
Biagio Ricciuti: How adaptive mechanisms and increased GTP loading confer resistance to KRAS G12C OFF
Biagio Ricciuti shared on X: “Our in Nature Communications our collaborative effort showing how adaptive mechanisms…
Sep 6, 2024, 13:23 | Dialogues
Liposarcoma Advances and Challenges - Sarcoma Talk #9 with Vinayak Venkataraman
In this edition of Sarcoma Talk on OncoDaily, Dr. Vinayak Venkataraman, a medical oncologist from…
Sep 6, 2024, 12:30 | Career
Mikkael A. Sekeres, Candidate for Secretary of ASH
Mikkael A. Sekeres, Chair of Committee on Communications at American Society of Hematology (ASH) is…
Sep 6, 2024, 02:23 | Insight
Gustavo Alencastro Veiga Cruzeiro: Diffuse hemispheric glioma, H3G34R/V-mutant
Mara Vinci, Chair of Biology SIOPE HGG Working Group, shared a post by Gustavo Alencastro…
Sep 5, 2024, 19:21 | Insight
Mariella Filbin: Our latest paper on pediatric/AYA glioma
Mariella Filbin shared a post on X by Gustavo Cruzeiro about a recent paper by…
Sep 5, 2024, 15:22 | Blog
Paolo Tarantino: Looking forward to join the Medscape symposium to review treatment landscape for HR+/HER2- metastatic breast cancer
Paolo Tarantino shared a post on LinkedIn: "Really looking forward to joining this Medscape symposium to…
Sep 5, 2024, 15:10 | Blog
Laurie H. Glimcher announced that she will assume the title of President Emerita
Who is Laurie H. Glimcher? Laurie H. Glimcher, MD, was named President and CEO of…
Sep 4, 2024, 15:08 | Blog
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
Paolo Tarantino shared a post on LinkedIn: "Two weeks to ESMO 2024. Multiple important breast…
Sep 4, 2024, 11:47 | Dialogues
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
In this episode of OncoDaily Interviews, Dr. Benjamin Schlechter, a distinguished medical oncologist at the…
Sep 3, 2024, 14:47 | Insight
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 13:49 | Insight
Article of the day, September 2nd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 08:40 | Blog
David Braun: We can make a personalized vaccine to target those tumor-specific antigens
Dana-Farber Cancer Institute shared a post on X: “'If we can identify neoantigens specific to…
Aug 31, 2024, 18:36 | Blog
Asaf Maoz: Looking Back, Facing Forward is coming up September 14th
Asaf Maoz, Medical Oncologist, Dana-Farber Cancer Institute, shared a post on X: "Looking Back, Facing…
Aug 29, 2024, 17:01 | Insight
Elad Sharon: Quite promising for c-MET over-expressing NSCLC
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Giuseppe Banna, Consultant…
Aug 29, 2024, 11:25 | Insight
Article of the day, August 29th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 29, 2024, 02:57 | Blog
Newly released ASCO principles for responsible use of AI in oncology
Toni Choueiri shared a post by Julie Gralow, adding: "Very important task force led by…
Aug 28, 2024, 13:52 | Insight
Article of the day, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 27, 2024, 17:21 | Insight
Review of precision therapeutics and emerging strategies in HR+ MBC
Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X: "Congratulations to Maxwell…
Aug 27, 2024, 12:26 | Blog
We honor the women in cancer care and beyond who have advocated for change - The Jimmy Fund
The Jimmy Fund shared on LinkedIn: "Today, we celebrate the many shining examples of work…
Aug 26, 2024, 20:03 | Blog
Laurie H. Glimcher has been named a 2024 “CEO to Know” by Becker's Healthcare - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Laurie H. Glimcher, MD, president and CEO…
Aug 24, 2024, 14:55 | Blog
Dana-Farber Cancer Institute celebrates Department of Quality and Patient Safety Staff Recognition Awards
Dana-Farber Cancer Institute shared on LinkedIn: "Oncology care requires stringent regulation and airtight processes to ensure…
Aug 24, 2024, 11:47 | Insight
Narjust Florez: Discussion with Julia Rotow about the MARIPOSA trial
Narjust Florez shared a post by IASLC on X, adding: “At The International Association for…
Aug 24, 2024, 06:53 | Insight
Srinivas Viswanathan: A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
Recently, an article by Srinivas Viswanathan et al. titled "A genetic basis for sex differences in…
Aug 21, 2024, 16:22 | Insight
Inaugural McGraw/Patterson Center Symposium: Community-Based Research and Cancer Care Equity - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, shared a post on LinkedIn: "The agenda for the inaugural McGraw/Patterson Center…
Aug 21, 2024, 14:03 | Blog
$3 million research grant to Dana-Farber Cancer Institute and UT Health San Antonio to study BRCA therapy
Dana-Farber Cancer Institute shared on LinkedIn: "Scientists at Dana-Farber's Center for BRCA and Related Genes in…
Aug 20, 2024, 10:02 | Blog
Toni Choueiri: Announcement for folks going to ESMO24
Toni Choueiri shared a post on X by Daniel Castellano, Medical Oncologist at University Hospital…
Aug 19, 2024, 17:09 | Blog
Ed Chouchani wins 2024 Emerging Leader Award - The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research posted on X: "Congratulations to 2024 Emerging Leader Award…
Aug 19, 2024, 14:45 | Insight
New Insights into Stage III NSCLC Treatment from Narjust Florez
Florez Lab shared on X: "In 2018, the PACIFIC trial revolutionized stage III NSCLC treatment…
Aug 19, 2024, 12:16 | Insight
Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?
Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…
Aug 19, 2024, 06:51 | Insight
Chiara Corti: Our ASCO Daily News editorial "IMpassion132"
Chiara Corti shared a post on LinkedIn: "Check out our American Society of Clinical Oncology…
Aug 18, 2024, 12:04 | Blog
Do lipids play a role in prostate cancer treatment resistance? - Chris O'Brien Lifehouse
Chris O'Brien Lifehouse shared on LinkedIn: "Do lipids play a role in prostate cancer treatment…
Aug 17, 2024, 08:50 | Insight
Karl Semaan: Our study on first-line systemic therapy after adjuvant immunotherapy in RCC
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X…
Aug 17, 2024, 08:18 | Societies
Highlights from KCancer by the Jimmy Fund
The Jimmy Fund, founded in Boston in 1948, consists of community-driven fundraising events and programs…
Aug 16, 2024, 14:13 | Insight
OS rates for IMpower133 and IMbrella A extension study in SCLC
Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…
Aug 16, 2024, 13:26 | Blog
Monica Bertagnolli's statement about NIH’s plans to protect the integrity of NIH-supported research
Monica Bertagnolli shared on LinkedIn: "Over the past several years, NIH (National Institutes of Health),…
Aug 15, 2024, 18:20 | Blog
Dana-Farber Cancer Institute - WEEI Sports Radio Network/NESN Jimmy Fund Radio-Telethon
Dana-Farber Cancer Institute shared on LinkedIn: "After successful treatment for leukemia at our Jimmy Fund Clinic,…
Aug 15, 2024, 13:41 | Blog
$15 million Program Project Grant from the NCI for research in endometrial cancer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Dana-Farber physician-scientists have received a five-year, $15…
Aug 15, 2024, 04:56 | Blog
Hung Trinh: A novel CAR-Enhancer to prevent relapse after CAR-T Therapy by Dana-Farber Cancer Institute
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Aug 14, 2024, 15:35 | Blog
Elad Sharon: So much we can do together to reduce the burden and suffering from cancer
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared a post by Danielle…
Aug 12, 2024, 22:05 | Insight
Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer
Varadha Balaji Venkadakrishnan, Postdoctoral Researcher at Dana-Farber Cancer Institute, shared on X about a recent…
Aug 12, 2024, 14:48 | Blog
Global study on the accuracy of HER2-low diagnoses among 77 pathologists from 14 countries
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute shared a recent article by Josef…
Aug 12, 2024, 02:37 | Blog
Biagio Ricciuti: Vulnerabilities to GPX4 and HDAC inhibitors in BRAF V600E lung adenocarcinoma
Biagio Ricciuti posted on X about recent paper by Marie-Julie Nokin et al., titled "In…
Aug 11, 2024, 21:32 | Blog
Full power of innovation to achieve the goals of The White House Cancer Moonshot initiative - Genomate Health
Genomate Health posted on LinkedIn: "As a CancerX Moonshot founding member, we collaborate with other…
Aug 11, 2024, 12:18 | Blog
Vinayak Venkataraman: Cancer research face several barriers at Journal of Clinical Oncology commentary
Vinayak Venkataraman, Medical Oncologist in the Sarcoma Center at Dana-Farber Cancer Institute, shared a post…
Aug 10, 2024, 16:06 | Blog
Conquer Cancer Awarded $1.45M to Dana-Farber Cancer Institute
Conquer Cancer, the ASCO Foundation shared on LinkedIn: "Recently, Conquer Cancer Awarded $1.45M to Dana-Farber Cancer…
Aug 10, 2024, 15:07 | Blog
The 2024 Damon Runyon Clinical Investigators
The Damon Runyon Cancer Research Foundation has announced six new recipients of the Damon Runyon…
Aug 10, 2024, 03:21 | Blog
Evanna Mills and Brenda Nakagaki will join Biomedical Sciences programs at the Pew Charitable Trusts - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: ''Evanna Mills and Brenda Nakagaki have been selected…
Aug 9, 2024, 10:15 | Blog
Laurie Glimcher: Lifesaving difference through the events of PMC Ride Weekend
Laurie Glimcher, President and CEO at Dana-Farber Cancer Institute, shared on X: "Every year, we…
Aug 7, 2024, 20:03 | Insight
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion summarized by Biagio Ricciuti
Biagio Ricciuti shared a post on X: "Recurrence of Non–Small Cell Lung Cancer With Visceral…
Aug 7, 2024, 03:08 | Blog
Kara Burke and Nina Camilli from Dana-Farber Cancer Institute were recognized with the DAISY Award
Dana-Farber Cancer Institute shared a post on LinkedIn: ''Kara Burke, a nurse at Dana-Farber - Longwood…
Aug 6, 2024, 16:27 | Blog
Insights from Dana-Farber Cancer Institute's 2024 Annual Recognition Awards
Dana-Farber Cancer Institute posted on LinkedIn: "At the 2024 Annual Recognition Awards, the wide range…
Aug 6, 2024, 13:07 | Insight
Wenxin Xu: Proud to finish my ride with Ocean State Cancer Crushers for PMC2024
Wenxin Xu, Genitourinary oncologist and clinical cancer researcher at Dana-Farber Cancer Institute and Assistant Professor…
Aug 6, 2024, 06:07 | Insight
Primary analysis of the phase 2 INSIGHT 2 study of tepotinib combined with osimertinib
Lungevity Foundation shared a recent article by Yi-Long Wu, commenting: "What's after osimertinib for pts…
Aug 5, 2024, 02:30 | Blog
Laurie Glimcher: Pan-Mass Challenge will raise $75 million in 2024 for Dana-Farber Cancer Institute
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared a post on X: "Good luck…
Aug 4, 2024, 12:18 | Insight
Toni Choueiri: Day 1 of Pan-Mass Challenge (85 miles) done
Toni Choueiri shared a post on X: “Day 1 of Pan-Mass Challenge (85 miles) done:…
Aug 4, 2024, 12:01 | Blog
Abby R. Rosenberg was named one of the most influential leaders in hospice and palliative care by the AAHPM - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Abby R. Rosenberg, Chief of Pediatric Palliative…
Aug 4, 2024, 11:39 | Blog
Ann Partridge has been awarded an American Cancer Society Professor Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Ann Partridge, vice chair of Medical Oncology,…
Aug 4, 2024, 10:02 | Blog
Narjust Florez: 3 years ago I started my job at Dana-Farber Cancer Institute
Narjust Florez shared on X: "3 years ago on this same date, I started my job…
Aug 3, 2024, 08:06 | Blog
From searching for answers to help a pregnant lung cancer patient to leading the International Pregnancy and Lung Cancer Registry - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Three years ago, Narjust Florez was searching for answers…
Aug 3, 2024, 01:28 | Blog
Neha Gaur has been named to Becker's Healthcare list of 42 Healthcare Leaders Under 40 for 2024 - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Congratulations to Neha Gaur, VP of Inpatient…
Aug 2, 2024, 13:25 | Blog
What is radon and how does it impact cancer risk? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “What is radon and how does it…
Aug 1, 2024, 15:35 | Insight
Harold Burstein: Thoughtful op-ed on multicancer ctDNA genomic screens by Hilary Robbins
Harold Burstein, Breast cancer specialist and Professor at Dana Farber Cancer Institute, shared a post on…
Aug 1, 2024, 02:29 | Blog
Early Intervention Key to Managing Shwachman-Diamond Syndrome: Insights from Dana-Farber's Molecular Tumor Board
Dana-Farber Cancer Institute shared a post on LinkedIn: "Imagine trying to navigate a paper map…
Jul 31, 2024, 11:17 | Insight
Gunsagar Gulati: Two extraordinary papers released on BioRxiv
Gunsagar Gulati, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X about two…
Jul 31, 2024, 07:26 | Insight
Allison O'Neill will be riding 162 miles over 2 days to raise money for pediatric cancer
Allison O'Neill, Pediatric Oncology physician-scientist at Dana-Farber Cancer Institute, shared on Facebook: “Dear Family and…
Jul 30, 2024, 13:03 | Insight
William Gibson: A general strategy for TP53 missense mutant cancers with prototype small molecules
Harold J. Burstein, Breast cancer specialist and professor at Dana Farber Cancer Institute, shared a…
Jul 30, 2024, 06:55 | Blog
New episode of Oncology for the Inquisitive Mind podcast: Palliative Care with Dr. Janet Abrahm
Oncology for the Inquisitive Mind shared a post on X: "This week, Dr. Janet Abrahm…
Jul 30, 2024, 01:45 | Insight
TKIs with vs without upfront SRS for EGFR+ and ALK+ NSCLC and brain metastasis
Biagio Ricciuti shared on X about a recent paper by Luke Pike et al. titled…
Jul 29, 2024, 11:50 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Toni Choueiri
We are pleased to highlight Dr. Toni Choueiri, a leading expert in genitourinary oncology, as…
Jul 28, 2024, 14:38 | Drugs
Elad Sharon: Contribution of effect is an under appreciated and essential part of drug development
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared a post by FDA Oncology…
Jul 27, 2024, 06:38 | Blog
The Jimmy Fund - Spotlighting Vinayak Venkataraman this Sarcoma Awareness Month
The Jimmy Fund shared on LinkedIn: “This Sarcoma Awareness Month, we’re spotlighting Vinayak Venkataraman, M.D., of…
Jul 24, 2024, 08:46 | Blog
Join us to discuss the new cancer hospital proposed by Dana-Farber
Dana-Farber Cancer Institute shared a post on LinkedIn: ''Join us to discuss the new cancer…
Jul 24, 2024, 01:00 | Blog
Chiara Corti: Over 1,900 downloads for our educational chapter on systemic therapy in breast cancer
Chiara Corti shared a post on LinkedIn about a recent paper titled "Systemic Therapy in Breast…
Jul 23, 2024, 00:18 | Blog
Notch signaling in advanced prostate cancer
Himisha Beltran, Associate Professor of Medicine at Dana Farber Cancer Institute, shared a post on…
Jul 22, 2024, 13:38 | Blog
Toni Choueiri: Excited for PMC2024 where over 7000 riders are focused on 1 mission
Toni Choueiri posted on X: "Last training ride before Pan-Mass Challenge ride on Team More…
Jul 21, 2024, 15:35 | Blog
Dean Crowe: Exciting to highlight the amazing accomplishments achieved through national advocacy
Dean Crowe, Founder and CEO at the Rally Foundation for Childhood Cancer Research, shared on LinkedIn:…
Jul 21, 2024, 12:10 | Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 21, 2024, 09:48 | Blog
New adult inpatient cancer hospital in the Longwood Medical Area by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "On Wednesday, July 24, 2024, please join…
Jul 20, 2024, 12:06 | Blog
Andrew Lane: Powerful segment produced by Medical Stories on one of my brave patients at Dana-Farber with BPDCN
Andrew Lane, Associate Chief of Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, shared a post…
Jul 19, 2024, 22:19 | Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 18, 2024, 12:58 | Blog
2024-2025 Best Hospitals by the U.S. News and World Report
The U.S. News & World Report published its 2024-2025 Best Hospitals rankings, marking the 35th anniversary of…
Jul 18, 2024, 10:05 | Insight
EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer
Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…
Jul 16, 2024, 10:50 | Blog
Social Determinants of Health with Large/Moderate Language Models on EHR Data
NCI Physical Sciences shared a post on X: Social Determinants of Health "On July 30…
Jul 15, 2024, 11:50 | Blog
Karl Semaan: Renee Maria Saliby presented her results on intermediate endpoints in patients with mRCC at KCRS24
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Star…
Jul 15, 2024, 09:22 | Blog
Craig Bunnell: My 10th Pan-Mass Challenge ride
Craig Bunnell, Chief Medical Officer at Dana-Farber Cancer Institute, shared on LinkedIn: "It's that time of year…
Jul 15, 2024, 06:31 | Positive
Karl Semaan received the Outstanding Research Award at KCRS24
Sylvan Baca, GU oncologist and computational epigenomics enthusiast at Dana-Farber Cancer Institute, shared on X:…
Jul 13, 2024, 07:56 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Paolo Tarantino
Our next oncoinfluencer is Dr. Paolo Tarantino. Dr. Tarantino is active on both X/Twitter and…
Jul 12, 2024, 23:29 | Insight
Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC
Biagio Ricciuti shared on X: "Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC…
Jul 12, 2024, 17:04 | Insight
Red Sox leadership as sports philanthropist of the year by ESPN - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn:  “Since 1953, Boston Red Sox leadership has championed the…
All: 345 Posts: 1 - 100
Special Coverage